MENU

PEN Stock Penumbra (PEN, $196.41) Moving Average Convergence Divergence (MACD) Histogram turned positive on June 6, 2024

A.I.dvisor
at Tickeron.com
06/07/24
Loading...
PEN - Penumbra
MACD signal
Bullish Trend
Odds of UP Trend
Tickeron
MACD signal
Price: $196.41
Daily change: +$3.12 (+1.61%)
Daily volume: 547.2K
Capitalization: $7.6B
Industry: Medical Specialties
This is a Bullish indicator signaling PEN's price could rise from here. Traders may explore going long the stock or buying call options. A.I. dvisor identified 44 similar cases where PEN's MACD histogram became positive, and of them led to successful outcomes. Odds of Success:

PEN in +3.86% Uptrend, rising for three consecutive days on November 11, 2024

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PEN advanced for three days, in of 327 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 29, 2024. You may want to consider a long position or call options on PEN as a result. In of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 247 cases where PEN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for PEN moved out of overbought territory on November 12, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 43 similar instances where the indicator moved out of overbought territory. In of the 43 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PEN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PEN broke above its upper Bollinger Band on October 31, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PEN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.138) is normal, around the industry mean (22.924). P/E Ratio (93.703) is within average values for comparable stocks, (83.945). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (8.052) is also within normal values, averaging (43.175).

View a ticker or compare two or three
PEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of medical devices

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
One Penumbra Place
Phone
+1 510 748-3200
Employees
4200
Web
https://www.penumbrainc.com